Related Experiment Videos
Immune effector cells: mast cells and eosinophils?
Shira Fraenkel1, Ilaria Puxeddu, Francesca Levi-Schaffer
1Department of Pharmacology, Hebrew University of Jerusalem, Jerusalem, Israel.
Pediatric Pulmonology. Supplement
|March 20, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Switching to dupilumab from other biologic therapies in chronic rhinosinusitis with nasal polyps (CRSWNP): a comparison with biologic-naïve patients.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2026
CD300a as a Potential Immune Checkpoint in Breast Cancer: Insights from in vivo and in vitro Models.
International archives of allergy and immunology·2026
Assessing residual allergenicity in heat-treated red lentil flours through simulated digestion, in vitro and in silico assays and peptidome approach.
Food research international (Ottawa, Ont.)·2026
The right drug at the right time: key to IBD success.
Trends in molecular medicine·2025
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026